Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUVELISIB vs EFALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DUVELISIB vs EFALIZUMAB: Safety Overview

Metric DUVELISIB EFALIZUMAB
Total FAERS Reports 757 230
Deaths Reported 165 73
Death Rate 21.8% 31.7%
Hospitalizations 282 44
Average Patient Age 64.7 yrs 52.3 yrs
% Female Patients 40.0% 46.2%
FDA Approval Date Sep 24, 2018 N/A
Manufacturer Secura Bio, Inc N/A
Route ORAL N/A
Marketing Status Prescription N/A